.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Citi
Julphar
Farmers Insurance
Deloitte
Harvard Business School
Fuji
Boehringer Ingelheim
Teva
Baxter

Generated: November 19, 2017

DrugPatentWatch Database Preview

DOXORUBICIN HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for doxorubicin hydrochloride and what is the scope of doxorubicin hydrochloride patent protection?

Doxorubicin hydrochloride
is the generic ingredient in five branded drugs marketed by Mylan Labs Ltd, Alvogen Inc, Janssen Res And Dev, Sun Pharm Inds, West-ward Pharms Int, Actavis Inc, Gland Pharma Ltd, Bristol Myers Squibb, Pharmacia And Upjohn, Pharmachemie Bv, Teva Pharms Usa, Sandoz Inc, Dr Reddys Labs Ltd, Sun Pharma Global, Fresenius Kabi Usa, Amneal Pharms Co, and Sagent Pharms, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for doxorubicin hydrochloride. Sixteen suppliers are listed for this compound.

Pharmacology for DOXORUBICIN HYDROCHLORIDE

Medical Subject Heading (MeSH) Categories for DOXORUBICIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION064140-002Jul 28, 1995APRXNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
RUBEX
doxorubicin hydrochloride
INJECTABLE;INJECTION062926-001Apr 13, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Janssen Res And Dev
DOXIL (LIPOSOMAL)
doxorubicin hydrochloride
INJECTABLE, LIPOSOMAL;INJECTION050718-002Jun 13, 2000ABRXYesNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION063097-003May 21, 1990APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION064097-001Sep 13, 1994APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION063097-002May 21, 1990APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION063336-001Feb 28, 1995APRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
doxorubicin hydrochloride
INJECTABLE, LIPOSOMAL;INJECTION208657-002May 15, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION063336-004Feb 28, 1995APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
ADRIAMYCIN PFS
doxorubicin hydrochloride
INJECTABLE;INJECTION063165-001Jan 30, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: doxorubicin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Res And Dev
DOXIL (LIPOSOMAL)
doxorubicin hydrochloride
INJECTABLE, LIPOSOMAL;INJECTION050718-001Nov 17, 1995► Subscribe► Subscribe
Janssen Res And Dev
DOXIL (LIPOSOMAL)
doxorubicin hydrochloride
INJECTABLE, LIPOSOMAL;INJECTION050718-002Jun 13, 2000► Subscribe► Subscribe
Janssen Res And Dev
DOXIL (LIPOSOMAL)
doxorubicin hydrochloride
INJECTABLE, LIPOSOMAL;INJECTION050718-002Jun 13, 2000► Subscribe► Subscribe
Janssen Res And Dev
DOXIL (LIPOSOMAL)
doxorubicin hydrochloride
INJECTABLE, LIPOSOMAL;INJECTION050718-001Nov 17, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Federal Trade Commission
Dow
US Department of Justice
US Army
McKesson
Daiichi Sankyo
Mallinckrodt
Cipla
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot